New York - Even as biologic therapies become available, there will still be a place for acitretin, methotrexate and cyclosporin-based treatment protocols, according to Mark Lebwohl, M.D.
Derm In The News: February 25-March 2
ReV Up Your Vitiligo Treatment Strategies
Pointers With Portela: Dangerous Skin Care Marketing
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Suicide Risk in Isotretinoin Users: New Data
Johnson & Johnson Innovative Medicine Sponsorship Expands GW Teledermatology Program
2 Commerce Drive Cranbury, NJ 08512